Volpara to distribute AI decision support software for breast cancer detection

Wellington-based medical technology company Volpara Health Technologies has signed a distribution agreement with Dutch firm ScreenPoint Medical to distribute its Transpara artificial intelligence solution for mammography in Australia and New Zealand.

Transpara is described as next-generation computer-aided detection software that has been designed to help radiologists read screening mammograms by marking specific areas of the breast image as likely to be cancer or not.

Posted in New Zealand eHealth

Tags: Volpara

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2020 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.